These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10964110)

  • 1. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.
    Rice JC; Ozcelik H; Maxeiner P; Andrulis I; Futscher BW
    Carcinogenesis; 2000 Sep; 21(9):1761-5. PubMed ID: 10964110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter.
    Rice JC; Futscher BW
    Nucleic Acids Res; 2000 Sep; 28(17):3233-9. PubMed ID: 10954590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors.
    Li Z; Chen B; Wu Y; Jin F; Xia Y; Liu X
    BMC Cancer; 2010 Mar; 10():98. PubMed ID: 20230646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
    Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
    Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
    Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
    Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
    Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
    Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
    Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
    Butcher DT; Rodenhiser DI
    Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers.
    Niwa Y; Oyama T; Nakajima T
    Jpn J Cancer Res; 2000 May; 91(5):519-26. PubMed ID: 10835497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.
    Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI
    Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
    Bianco T; Chenevix-Trench G; Walsh DC; Cooper JE; Dobrovic A
    Carcinogenesis; 2000 Feb; 21(2):147-51. PubMed ID: 10657950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
    Hasan TN; Leena Grace B; Shafi G; Syed R
    Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
    Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
    FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
    Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
    Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.
    Cerne JZ; Zong L; Jelinek J; Hilsenbeck SG; Wang T; Oesterreich S; McGuire SE
    Breast Cancer Res Treat; 2012 Aug; 135(1):135-43. PubMed ID: 22706629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.